{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:13:07Z","timestamp":1763017987356,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470256"],"award-info":[{"award-number":["81470256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.lfs.2019.01.021","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T20:59:33Z","timestamp":1547585973000},"page":"329-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["sSema4D levels are increased in coronary heart disease and associated with the extent of coronary artery stenosis"],"prefix":"10.1016","volume":"219","author":[{"given":"Hui","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.01.021_bb0005","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"M. Writing Group","year":"2016","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2019.01.021_bb0010","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1111\/jth.12972","article-title":"Acute and persistent platelet and coagulant activities in atherothrombosis","volume":"13","author":"Mastenbroek","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2019.01.021_bb0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2169\/internalmedicine.54.3003","article-title":"Rivaroxaban therapy resulting in the resolution of right atrial thrombosis resistant to ordinary control with warfarin in a patient with atrial fibrillation","volume":"54","author":"Hiroaki","year":"2015","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2019.01.021_bb0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2183\/pjab.86.611","article-title":"Semaphorins and their receptors: novel features of neural guidance molecules","volume":"86","author":"Kumanogoh","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.lfs.2019.01.021_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fcvm.2018.00136","article-title":"CD100 effects in macrophages and its roles in atherosclerosis","volume":"5","author":"Luque","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.lfs.2019.01.021_bb0030","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/annrheumdis-2016-210706","article-title":"Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis","volume":"76","author":"Nishide","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2019.01.021_bb0035","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.0606344104","article-title":"Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2019.01.021_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.humimm.2009.01.026","article-title":"Expression and function of semaphorin3A and its receptors in human monocyte-derived macrophages","volume":"70","author":"Ji","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0045","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1074\/jbc.M609570200","article-title":"MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D","volume":"282","author":"Basile","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2019.01.021_bb0050","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1523\/JNEUROSCI.0799-12.2012","article-title":"Semaphorin 4D\/Plexin-B1-mediated M-Ras GAP activity regulates actin-based dendrite remodeling through Lamellipodin","volume":"32","author":"Tasaka","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2019.01.021_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrn3302","article-title":"Getting neural circuits into shape with semaphorins","volume":"13","author":"Pasterkamp","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.lfs.2019.01.021_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ni1553","article-title":"Semaphorins and their receptors in immune cell interactions","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0065","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1158\/0008-5472.CAN-04-0126","article-title":"Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B","volume":"64","author":"Basile","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2019.01.021_bb0070","first-page":"16352","article-title":"Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2019.01.021_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00011-016-0983-5","article-title":"Semaphorins 4A and 4D in chronic inflammatory diseases","volume":"66","author":"Chapoval","year":"2017","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.lfs.2019.01.021_bb0080","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1349-7006.2011.02053.x","article-title":"Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer","volume":"102","author":"Kato","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2019.01.021_bb0085","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/ATVBAHA.109.185405","article-title":"Disruption of SEMA4D ameliorates platelet hypersensitivity in dyslipidemia and confers protection against the development of atherosclerosis","volume":"29","author":"Zhu","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/ijmm_00000432","article-title":"Deletion of Sema4D gene reduces intimal neovascularization and plaque growth in apolipoprotein E-deficient mice","volume":"26","author":"Yukawa","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2019.01.021_bb0095","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacc.2013.05.016","article-title":"High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?","volume":"62","author":"Yousuf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0105","first-page":"611","article-title":"Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation","volume":"93","author":"Tetsunori","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075772","article-title":"Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells","volume":"8","author":"Luque","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.01.021_bb0115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","article-title":"A more meaningful scoring system for determining the severity of coronary heart disease","volume":"51","author":"Gensini","year":"1983","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2019.01.021_bb0125","article-title":"Plexin-B1 activates NF-kappaB and IL-8 to promote a pro-angiogenic response in endothelial cells","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2019.01.021_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molimm.2015.07.028","article-title":"CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis","volume":"67","author":"Luque","year":"2015","journal-title":"Mol. Immunol."},{"issue":"25","key":"10.1016\/j.lfs.2019.01.021_bb0135","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1182\/blood-2010-04-279943","article-title":"Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking semaphorin 4D","volume":"116","author":"Wannemacher","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lfs.2019.01.021_bb0140","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1182\/blood-2004-07-2885","article-title":"Sema4D induces angiogenesis through Met recruitment by Plexin B1","volume":"105","author":"Conrotto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2019.01.021_bb0145","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.12659\/MSM.895441","article-title":"Serum soluble semaphorin 4D is associated with left atrial diameter in patients with atrial fibrillation","volume":"21","author":"Xiang","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lfs.2019.01.021_bb0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ehf2.12275","article-title":"Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?","volume":"5","author":"Willner","year":"2018","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.lfs.2019.01.021_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ahj.2012.12.020","article-title":"Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review","volume":"165","author":"Bawamia","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.lfs.2019.01.021_bb0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.62.2.207","article-title":"Is there a left main equivalent","volume":"62","author":"Hutter","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2019.01.021_bb0165","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis","volume":"54","author":"Libby","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.atherosclerosis.2008.08.009","article-title":"Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease","volume":"204","author":"Arroyo-Espliguero","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2019.01.021_bb0175","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","article-title":"High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy","volume":"168","author":"Koenig","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.hjc.2016.08.004","article-title":"Extent of coronary artery disease in patients undergoing angiography for stable or acute coronary syndromes","volume":"58","author":"Marini","year":"2017","journal-title":"Hell. J. Cardiol."},{"key":"10.1016\/j.lfs.2019.01.021_bb0185","first-page":"4294","article-title":"Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion","volume":"20","author":"Ma","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519300323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519300323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:44:36Z","timestamp":1565214276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519300323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"alternative-id":["S0024320519300323"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.01.021","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"sSema4D levels are increased in coronary heart disease and associated with the extent of coronary artery stenosis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}